Skip to main content

Drugs: Misuse

Volume 478: debated on Thursday 26 June 2008

To ask the Secretary of State for Health how many hospital admissions where the primary or secondary diagnosis was drug-related there were in Suffolk in each of the last five years, broken down by age. (209392)

The following table shows total admissions to hospital in which the primary or secondary diagnosis of the patient was drug related in Suffolk, broken down by age, for 2002-03 to 2006-07.

Admissions are classified using the International Classifications of Diseases (ICD) 10 codes. A “drug” can be defined as any substance that alters normal bodily function. Therefore codes relating to noxious substances and solvents have been included in this data. It is not possible to identify in ICD-10 all diseases caused by drugs (legal or illegal) and there is no way to guarantee that the admission was drug related. For example, a patient admitted for inguinal hernia surgery may also be dependent on a drug.

Year (of end of first period of care in patient's hospital stay)Age2002-032003-042004-052005-062006-07Under 1514417822116413715 to 641,4061,7321,5141,5641,55965+399489529579606Unknown———1— Notes: 1. Suffolk primary care trust (PCT): In 2006, Suffolk PCT was formed from four former PCTs: Suffolk Coastal PCT, Ipswich PCT, Central Suffolk PCT, Suffolk West PCT. 2. Finished admission episodes (FAEs): A FAE is the first period of in-patient care under one consultant within one health care provider. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year. 3. Data quality: HES are compiled from data sent by over 300 national health service trusts and primary care trusts (PCTs) in England. The Information Centre for health and social care liaises closely with these organisations to encourage submission of complete and valid data and seeks to minimise inaccuracies and the effect of missing and invalid data via HES processes. Whilst this brings about improvement over time, some shortcomings remain. 4. Assessing growth through time: HES figures are available from 1989-90 onwards. During the years that these records have been collected by the NHS there have been ongoing improvements in quality and coverage. These improvements in information submitted by the NHS have been particularly marked in the earlier years and need to be borne in mind when analysing time series. Changes in NHS practice also need to be borne in mind when analysing time series. For example a number of procedures may now be undertaken in outpatient settings and may no longer be accounted in the HES data. This may account for any reductions in activity over time. 5. All Diagnoses count of episodes—primary and secondary—“drug related”: These figures represent a count of all FAEs where the diagnosis was mentioned in any of the 14 (seven prior to 2002-03) diagnosis fields in a HES record. 6. ICD 10 Codes included in this data:Code F55 relates to the abuse of non-dependence-producing substances. Codes K71.0 through to K71.9 relate to toxic liver disease with cholestasis, with hepatic necrosis, with acute hepatitis, with chronic persistent hepatitis, with chronic lobular hepatitis, with chronic active hepatitis, with hepatitis not elsewhere classified, with fibrosis and cirrhosis of liver, with other disorders of liver, and with unspecified conditions. Codes T36 through to T65 relate to poisoning, such as poisoning by systemic antibiotics, other systemic anti-infectives and antiparasitics, hormones and their synthetic substitutes and antagonists not elsewhere classified, by nonopioid analgesics, antipyretics and antirheumatics, narcotics and psychodysleptics [hallucinogens], anaesthetics and therapeutic gases, antiepileptic, sedative-hypnotic and antiparkinsonism drugs, psychotropic drugs not elsewhere classified, psychotropic drugs not elsewhere classified, psychotropic drugs not elsewhere classified, drugs primarily affecting the autonomic nervous system, primarily systemic and haematological agents, not elsewhere classified, agents primarily affecting the cardiovascular system, agents primarily affecting the gastrointestinal system, agents primarily acting on smooth and skeletal muscles and the respiratory system, topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs, diuretics and other and unspecified drugs, medicaments and biological substances, toxic effect of organic solvents, toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons, toxic effect of corrosive substances, toxic effect of soaps and detergents, toxic effect of metals, toxic effect of other inorganic substances, toxic effect of carbon monoxide, toxic effect of other gases, fumes and vapours, toxic effect of pesticides, toxic effect of noxious substances eaten as seafood, toxic effect of other noxious substances eaten as food, toxic effect of contact with venomous animals, toxic effect of aflatoxin and other mycotoxin food contaminants, toxic effect of other and unspecified substances. Codes X40 through to X49 relate to accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, narcotics and psychodysleptics [hallucinogens] not elsewhere classified, other drugs acting on the autonomic nervous system, other and unspecified drugs, medicaments and biological substances, organic solvents and halogenated hydrocarbons and their vapours, other gases and vapours, exposure to pesticides, other and unspecified chemicals and noxious substances. Codes X60 through to X69 relate to intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, narcotics and psychodysleptics [hallucinogens], not elsewhere classified, other drugs acting on the autonomic nervous system, other and unspecified drugs, medicaments and biological substances, organic solvents and halogenated hydrocarbons and their vapours, exposure to pesticides, other and unspecified chemicals and noxious substances. Codes Y40 through to Y59 relate to systemic antibiotics, other systemic anti-infectives and antiparasitics, hormones and their synthetic substitutes and antagonists not elsewhere classified, primarily systemic agents, agents primarily affecting blood constituents, analgesics, antipyretics and anti-inflammatory drugs, antiepileptic and antiparkinsonism drugs, sedatives, hypnotics and antianxiety drugs, anaesthetics and therapeutic gases, psychotropic drugs not elsewhere classified, central nervous system stimulants, not elsewhere classified, drugs primarily affecting the autonomic nervous system, agents primarily affecting the cardiovascular system, agents primarily affecting the gastrointestinal system, agents primarily affecting water-balance and mineral and uric acid metabolism, agents primarily acting on smooth and skeletal muscles and the respiratory system, topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs, other and unspecified drugs and medicaments, Bacterial vaccines and Other and specified vaccines and biological substances. Codes T80 through to T80.9 relate to air embolism following infusion, transfusion and therapeutic injection, vascular complications following infusion, transfusion and therapeutic injection, infections following infusion, transfusion and therapeutic injection, other complications following infusion, transfusion and therapeutic injection, unspecified complication following infusion, transfusion and therapeutic injection. Codes T88.0 through to T88.7 relate to injection following immunization, other complications following immunization, not elsewhere classified, shock due to anaesthesia, malignant hyperthermia due to anaesthesia, other complications of anaesthesia, anaphylactic shock due to adverse effect of correct drug or medicament properly administered, unspecified adverse effect of drug or medicament. Code Z71.5 relates to drug abuse counselling and surveillance. Code T96.X through to Code T97.X relate to sequelae of poisoning by drugs, medicaments and biological substances and sequelae of toxic effects of substances chiefly nonmedicinal as to source. Code Z50.3 relates to drug rehabilitation. 7. Ungrossed Data: Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed). Source: Hospital Episode Statistics (HES), The Information Centre for health and social care.